• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Kadmon Pharmaceuticals

Anonymous board for Kadmon Pharmaceuticals
Replies
1
Views
3K
anonymous
Replies
4
Views
4K
anonymous
Replies
5
Views
5K
anonymous
Replies
3
Views
3K
anonymous
Replies
8
Views
5K
anonymous
Replies
34
Views
25K
anonymous
Replies
0
Views
3K
Anonymous
Replies
3
Views
5K
Anonymous
Replies
3
Views
8K
Anonymous